Many human cancers feature oncogenic alterations in PIK3CA, and not only do these often occur with mutations in other pathway components, but our data demonstrate the frequent presence of more than one mutant PIK3CA copy, suggesting that cancer cells benefit from additional PI3K pathway activation. The gene discussed is PIK3CA; the disease is cancer.